Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial

Nakajima, Atsushi ; Seki, Mitsunori ; Taniguchi, Shinya

Journal of gastroenterology, 2018-04, Vol.53 (4), p.525-534 [Periódico revisado por pares]

Tokyo: Springer Japan

Texto completo disponível